3-morpholin-4-yl-N-[3-[[(2-pyrrolidin-2-ylacetyl)amino]methyl]phenyl]propanamide;dihydrochloride
C20H32Cl2N4O3 — CID 119849221
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-morpholin-4-yl-N-[3-[[(2-pyrrolidin-2-ylacetyl)amino]methyl]phenyl]propanamide;dihydrochloride
3-morpholin-4-yl-N-[3-[[(2-pyrrolidin-2-ylacetyl)amino]methyl]phenyl]propanamide;dihydrochloride (PubChem CID 119849221) has the molecular formula C20H32Cl2N4O3 and a molecular weight of 447.41 g/mol. Its IUPAC name is 3-morpholin-4-yl-N-[3-[[(2-pyrrolidin-2-ylacetyl)amino]methyl]phenyl]propanamide;dihydrochloride.
Molecular Properties
| Compound Name | 3-morpholin-4-yl-N-[3-[[(2-pyrrolidin-2-ylacetyl)amino]methyl]phenyl]propanamide;dihydrochloride |
|---|---|
| PubChem CID | 119849221 |
| Molecular Formula | C20H32Cl2N4O3 |
| Molecular Weight | 447.41 g/mol |
| Exact Mass | 446.19 |
| IUPAC Name | 3-morpholin-4-yl-N-[3-[[(2-pyrrolidin-2-ylacetyl)amino]methyl]phenyl]propanamide;dihydrochloride |
| SMILES | Cl.Cl.O=C(CC1CCCN1)NCc1cccc(NC(=O)CCN2CCOCC2)c1 |
| InChI | InChI=1S/C20H30N4O3.2ClH/c25-19(6-8-24-9-11-27-12-10-24)23-18-4-1-3-16(13-18)15-22-20(26)14-17-5-2-7-21-17;;/h1,3-4,13,17,21H,2,5-12,14-15H2,(H,22,26)(H,23,25);2*1H |
| InChIKey | YIPOWJPICCKARO-UHFFFAOYSA-N |
| XLogP | 1.95 |
| TPSA | 82.70 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 29 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 447.41 |
| LogP ≤ 5 | 1.95 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 119849221 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.